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Many essential biological processes are mediated by complex molecular machines comprising multiple
subunits. Knowledge on the architecture of individual subunits and their positions within the overall multimeric
complex is key to understanding the molecular mechanisms of macromolecular assemblies. The
anaphase-promoting complex/cyclosome (APC/C) is a large multisubunit complex that regulates cell cycle
progression by ubiquitinating cell cycle proteins for proteolysis by the proteasome. The holo-complex is
composed of 15 different proteins that assemble to generate a complex of 20 subunits. Here, we describe the
crystal structures of Apc4 and the N-terminal domain of Apc5 (Apc5N). Apc4 comprises a WD40 domain split
by a long α-helical domain, whereas Apc5N has an α-helical fold. In a separate study, we had fitted these
atomic models to a 3.6-Å-resolution cryo-electron microscopy map of the APC/C. We describe how, in the
context of the APC/C, regions of Apc4 disordered in the crystal assume order through contacts to Apc5,
whereas Apc5N shows small conformational changes relative to its crystal structure. We discuss the
complementary approaches of high-resolution electron microscopy and protein crystallography to the
structure determination of subunits of multimeric complexes.
© 2015MRCLaboratory ofMolecular Biology. Published byElsevier Ltd. This is an open access article under theCCBY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
The anaphase-promoting complex/cyclosome
(APC/C) is a large multimeric cullin-RING E3
ubiquitin ligase that functions to regulate cell cycle
transitions by ubiquitinating specific cell cycle
regulatory proteins and targeting them for proteolysis
by the ubiquitin-proteasome system [1–5]. In verte-
brates, the holoenzyme is a complex of 15 different
proteins that assemble into a complex of 20 subunits
with a molecular mass approaching 1.2 MDa. Its
activity is strictly dependent on the association with
the core APC/C of a coactivator subunit (either
Cdc20 or Cdh1) that acts both to recruit substrates to
the APC/C and to stimulate its E3 ligase catalytic
activity [6–15]. Substrate recognition is conferred byaboratory of Molecular Biology. Published by
/licenses/by/4.0/).short destruction motifs (D box, KEN box and ABBA
motifs [16–19]) that interact with coactivator subunits
[7–12]. The core APC/C subunit Apc10 contributes
to D box recognition through a D box coreceptor
formed with coactivator [13,20,21]. Coactivators
increase APC/C activity by promoting an increase
in affinity for E2 and by enhancing E2 catalytic
efficiency [13–15]. Switching coactivators in late
mitosis changes substrate specificities and confers
the capacity of the APC/C to ubiquitinate substrates
in a cell-cycle-dependent manner.
The key role of APC/CCdc20 is to regulate
chromosome segregation in mitosis (reviewed in
Refs. [2–5]). APC/CCdc20 controls the proteolysis of
securin and cyclin B, inhibitors of the protease
separase (reviewed in Refs. [1–5]). ActivatedElsevier Ltd. This is an open access article under the CC BY license
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responsible for sister chromatid cohesion. APC/
CCdh1 in contrast regulates mitotic exit, the events of
cytokinesis and initiation of DNA replication. The APC/
C itself controls the switching of Cdc20 and Cdh1
coactivatorsby regulating the level of cyclin-dependent
kinase (CDK)-dependent phosphorylation of core
APC/C subunits and Cdh1. Phosphorylation of the
APC/C stimulates Cdc20 binding [22,23], whereas
Cdh1 phosphorylation negatively regulates its binding
to the APC/C [24,25].
A striking feature of the APC/C is its large size.
Only four subunits are directly involved in catalyzing
protein ubiquitination (the cullin subunit Apc2 and
the RING subunit Apc11) [15,26–31] and degron
recognition [coactivator subunits (either Cdc20 or
Cdh1) and Apc10] [7–13,20,21,32] (reviewed in
Refs. [2] and [4]). The remaining 85% of the
APC/C mass corresponds to scaffolding subunits,
of which seven are large multiple repeat motif
proteins (Apc1 and Apc3–Apc8). Four of these are
the canonical tetratricopeptide repeat (TPR) proteins
Apc3, Apc6, Apc7 and Apc8 that form structurally
related homodimers [33–37], whereas Apc1 com-
prises a proteasome cyclosome repeat domain
related in structure to the proteasome cyclosome
domain of the proteosomal subunits Rpn1 and Rpn2
[38,39]. Apc5 also includes 13 predicted TPR motifs
[40], whereas Apc4 comprises a putative WD40
domain. In addition to coordinating the juxtaposition
of the catalytic and substrate recognition modules,
scaffolding subunits contribute to catalysis, sub-
strate recognition and regulation. For example, Apc1
and Apc3 incorporate the major CDK-dependent
phosphorylation sites [23,41,42] responsible for
stimulating Cdc20 association, and in the case of
Apc3, these provide docking sites for the Cks
subunit of cyclin–CDK–Cks complexes [43].
Through the combination of single-particle cryo-
electron microscopy (cryo-EM) of both endogenous
and reconstituted complexes with crystallographic
analysis and atomic modeling of individual subunits,
pseudo-atomic structures of a large proportion of the
APC/C have been established. Recently, we report-
ed a 7.4-Å-resolution reconstruction of a ternary
complex of human APC/C with the coactivator Cdh1
and a fragment of the high-affinity substrate Hsl1
[13]. This allowed the complete secondary structure
assignment of the APC/C and the assignment of all
20 subunits of the complex to their respective
segments of the electron microscopy (EM) density
map. However, atomic models for Apc4 and the
N-termini of both Apc1 (~1100 residues) and Apc5
[~200 residues (Apc5N)] were lacking because no
crystal structures were available and their homology
to proteins of known structure was insufficient to
allow the generation of reliable atomic models.
Seeking to obtain insights into these structures at
atomic resolution and to assist in the interpretation ofcryo-EM reconstructions of the APC/C complex, we
determined the crystal structures of full-length Apc4
and the N-terminal domain of Apc5 (Apc5N).
We docked these atomic models into a 3.6-Å-
resolution cryo-EM reconstruction of the human
APC/CCdh1.Emi1 complex we had simultaneously
determined [44]. Here, we provide a detailed
analysis of the crystal structures of Apc4 and
Apc5N and the structures of Apc4 and Apc5 within
the context of the whole APC/C. In the complex,
regions of Apc4 disordered in the crystal assume
order through contacts to Apc5, whereas Apc5N
shows small conformational changes relative to its
crystal structure. The Apc4 WD40 domain
(Apc4WD40) is well resolved in the crystal structures
but is less well defined in the cryo-EM density map
due to its peripheral location in the APC/C. We
compare and contrast the differences between the
crystallographic and EM densities and highlight the
complementary approaches of high-resolution EM
and protein crystallography to the structure determi-
nation of subunits of multimeric complexes.Results and Discussion
Apc4 is a WD40 repeat protein with an α-helical
bundle insert
We first determined the crystal structure of
Xenopus laevis Apc4 (residues 1–741 that lacked
the C-terminal 48 residues that were predicted to be
disordered [45]). The protein was overexpressed in
the insect cell/baculovirus system and the structure
was determined using phases to 3.2 Å resolution
derived from multiwavelength anomalous diffraction.
Tracing of the polypeptide chain was guided by
selenomethionine anomalous signals (Supplementary
Table 1). We used the Xenopus Apc4 coordinates to
determine the full-length human Apc4 structure to a
similar resolution by molecular replacement (Supple-
mentary Table 2). As a result of contacts with Apc5,
regions of Apc4, disordered in both the Xenopus and
human crystal structures, are defined in theEMdensity
map of the 3.6-Å-resolution cryo-EM reconstruction of
human APC/CCdh1.Emi1 [44] (Supplementary Fig. 1).
The human Apc4 crystal structure was fitted
into the 3.6-Å-resolution cryo-EM density map of
APC/CCdh1.Emi1 [44] using Chimera [46] (Fig. 1 and
Supplementary Fig. 2c). Residues of the Apc4
helical bundle domain HBD (Apc4HBD) were
well resolved in EM density, and segments of the
Apc4HBD not visible in the crystal structures could be
built ab initio into the EM density, allowing an almost
complete atomic model to be generated and refined
[44] (Supplementary Fig. 1). C-terminal residues
(758–808) of human Apc4 are disordered in both the
crystal structure and the EM density map. In
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Fig. 1. Apc4 comprises a WD40 β-propeller toroid split by a helical bundle domain. (a) Cartoon of Apc4 color-ramped
from blue to red from N- to C-termini. Shown is the EM structure of human Apc4. (b) Close-up view of the extended blade 5
of Apc4WD40 and showing the βD4/βA5 loop that blocks access to the mouth of the WD40 domain tunnel. (c) Stereoview
showing that the M-domain of α-catenin, superimposed onto the EM structure of human Apc4HBD, shares structural
similarity with the four-helical-bundle domain of Apc4.
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domain, which is well resolved and ordered in the
crystal structures, is less well defined in the EM
density, being located at the periphery of the
complex (Supplementary Fig. 2b).
Apc4 adopts a bi-domain architecture, dominated by
a 360-residue seven-bladedWD40β-propeller domain
(Apc4WD40) split by theHBD (Apc4HBD) predominantly
composed of four long α-helices (Fig. 1a and
Supplementary Fig. 1). Apc4HBD is inserted between
strands C and D of blade 4 of the WD40 domain,
extending away from the wider lower surface of the
β-propeller such that, together, the HBD and WD40
domain generate an L-shaped molecule. A secondsmaller insert between β-strands A and B within blade
3 of Apc4WD40 contacts Apc4HBD. Finally, an insert
between β-strands C and D of blade 6 forms an edge
β-strand (βE5) with β-strand D of blade 5 (Fig. 1b and
Supplementary Fig. 1). Apart from these three
insertions, Apc4WD40 resembles a canonical β-propel-
ler architecture as judged by its similarity with other
WD40 domain proteins (Table 1) (high DALI Z scores
[47]). Structure prediction programs were unable to
correctly model the β-propeller due to the HBD insert.
To our knowledge, the insertion of a helical bundle
domain within a WD40 β-propeller domain is novel.
The four longα-helices that dominateApc4HBD sharea
structural similarity and antiparallel arrangement with
Table 1. DALI matches (top 3 matches)
Search protein Protein match PDB Z RMSD
(Å)
Nali Nres % ID
Apc5N RNP assembly factor 3zv0-B 5.7 3.5 115 329 10
Polybromo-1 3iu6-A 4.5 3.1 82 143 7
RBCX protein 3q20-A 4.5 3.4 77 114 10
Apc5TPR Malt regulatory protein 1hz4-A 22.7 3.4 325 366 12
NPRR 4gpk-L 18.2 5.8 320 346 9
Cut9 (Apc6) (8th) 2xpi-A 16.1 3.7 340 520 12
Apc4WD40 Polycomb protein EED WD40 protein 3iic-A 25.0 3.1 312 357 10
eiF3 subunit WD40 protein 3zwl-D 24.2 3.1 285 352 10
WDR5 WD40 protein 2h14-A 24.0 3.1 280 303 12
Apc4HBD Cytochrome c oxidase 1m56-C 12.0 3.0 129 265 4
Outer surface protein C 1f1m-C 10.7 2.7 133 162 11
α-Catenin 1h6g-A 10.7 2.7 129 255 6
3303Atomic-Resolution Structures of Apc4 and Apc5the four-helix bundle of domain 2 of the M-fragment of
α-catenin [48] (Fig. 1c and Table 1).
There are extensive contacts between Apc4HBD
and both the bottom surface and the strand surface
of the second, third and fourth blades of Apc4WD40
(Fig. 1a). This packing interaction confers stability
to the tertiary structure of Apc4, and small-angle
X-ray scattering (SAXS) analysis confirmed that
the solution structure is consistent with the X-rayApc4EM 
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Fig. 2. The Apc4–Apc5 protein interface orders regions of A
with the X-ray structure of Apc4 (red) superimposed onto the EM
(b) As in (a) but without Apc5. (c) Stereoview showing that th
similar (RMSD is 2.1 Å).structure (Supplementary Fig. 2c). Moreover, super-
imposing the Apc4 model from the crystal structure
onto the EM-derived structure [44] showed that,
except for the ordering of regions of Apc4HBD, the
conformation of Apc4 does not change in the context
of the APC/C, indicating that the HBD and WD40
domains are rigidly associated (Fig. 2a and b).
Human and X. laevis Apc4 are also very similar,
differing only for residues 120–130 (X. laevis Apc4pc4Hs 
pc4Xl 
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pc4HBD. (a) Human Apc4–Apc5 as organized in the APC/C
coordinates (brown). The Apc4–Apc5 interface is shown.
e crystal structures of X. laevis and human Apc4 are very
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α-helix in the X. laevis Apc4 structure in contrast to a
predominantly disordered loop structure in human
Apc4 (Fig. 2c and Table 2).
Conformational changes of Apc4 from the crystal
structures in the context of the whole APC/C
Overall, the crystal and EM structures of Apc4 differ
byanRMSDof 2.5 Å (Fig. 2aandTable 2).Differences
between the Apc4 crystal and EM structures relate
primarily to the tip of Apc4HBD. These involve
conformational changes and creation of newα-helices.
In the context of the APC/C, due to interactions with
Apc5, regions of Apc4 that are disordered in the crystal
structures adopt ordered α-helical conformations (α4,
α9andα10) (Fig. 2aandb).Helixα4, locatedat theend
ofApc4HBD, formsspecific contacts toApc5N,whereas
α10 becomes ordered due to packing against the TPR
domain of Apc5TPR. Ordering of the tip of Apc4HBD
induces a 45° bend toward the C-terminus of α3, a
smaller bend of α6, a shift and extension of α5 and
repositioning of α8. Finally,α9 forms to connect α8with
α10.
Figure 3 shows a comparison of the EM density and
X-ray (2Fo − Fc) maps of human Apc4, determined to
similar resolutions, 3.6 Å and 3.4 Å, respectively. In
the EM density map, secondary structural features are
well defined, whereas secondary structural elements
at the tip andperiphery of Apc4HBD that are resolved in
the EM density map are disordered in the X-ray
structure (α4, α9 and α10). For both EM and X-ray
maps, within the core of Apc4HBD, amino acid side-
chain densities are of comparable quality, allowing ab
initio fitting of the polypeptide sequence (Fig. 4).
In contrast, whereas the X-ray map shows well-
resolved side-chain densities for residues of Apc4WD40
(Fig. 5a), in the EM map, these side chains are poorly
defined, particularly for residues of Apc4WD40 at the
periphery of the APC/C, for example, blades 5 and 6
(Fig. 5b). Thus, regions of Apc4 that assumeorder only
in the context of their interaction with the neighboring
Apc5 subunit of the APC/C are visible in the EM map.
Apc4WD40 is less well defined in the EMmap due to its
location at the periphery of the molecule where it
engages in few intersubunit contacts (Supplementary
Fig. 2b), and EM maps have the largest alignment
inaccuracies. Additionally, structural variability due to
relative intersubunit rotations may be amplified at the
periphery of the molecule. In the human Apc4 crystal,Table 2. RMSD of Apc4 and Apc5 X-ray and EM models
Subunit H.s. Apc4EM H.s. Apc4
H.s. Apc4EM — 2.4 Å
H.s. Apc4X-ray — —
H.s. Apc5EM — —Apc4WD40 is secured through lattice contacts with two
neighboring molecules (data not shown).
Apc5 is a TPR protein with an N-terminal α-helical
domain
Bioinformatics analysis of Apc5 had previously
identified Apc5 as a variant TPR protein comprising
13 contiguous TPR-like motifs (residues 206–740),
C-terminal to a small α-helical domain [40]. Whereas
the canonical TPR is a 34-amino-acid motif [49,50],
in Apc5, the repeat varies in length from 34 to 40
amino acids. However, consistent with a TPR
protein, the consensus TPR residues (small aliphatic
at positions 8, 20 and 27; larger aliphatic residues at
positions 1, 4, 7, 10, 24 and 28) [49] are present in
Apc5 TPR motifs [40]. Residues 1–208 N-terminal to
the TPR domain do not conform to a TPR consensus
sequence and no repeat motif was detected using
TPRpred [51] and HHrep [52]. Based on secondary
structure prediction (Phyre2 [53]) and structure
disorder programs (OnD-CRF [45]), residues
1–160 were predicted to be ordered and α-helical,
with a disordered linker of ~30 residues connecting
this helical domain to the TPR domain. We purified
residues 1–161 of X. laevis Apc5 as a bi-product of
the Apc4–Apc5N coexpression system and crystal-
lized the protein. The structure was determined to
2.2 Å resolution using single-wavelength anomalous
diffraction phasing (Supplementary Table 2).
Apc5N [residues 27–161 (human Apc5 number-
ing)] adopts an all α-helical domain architecture
comprising seven α-helices (Fig. 6a and Supple-
mentary Fig. 6). Helices α1–α6 pack to create an
antiparallel bundle with α1 at the center of the
domain almost completely surrounded by helices
α2–α6. This α-helical domain is capped by α7,
orientated orthogonally to the α-helical domain. The
X-ray structure of X. laevis Apc5N was readily docked
into the assigned density of the 3.6-Å-resolution EM
density map of human APC/CCdh1.Emi1 [44] (Supple-
mentary Fig. 2a). A small shift of the loop connecting
α5 with α6 accommodates the Apc4–Apc5 interface
within the context of the APC/C (Fig. 6b). A larger
6-Å-conformational change involving the loop con-
necting α1 with α2 and the N-terminus of α2 results
from both packing at the Apc4–Apc5 interface and a
two-residue insertion within human Apc5 relative to X.
laevis Apc5 (Supplementary Fig. 3). Residues 1–26 of
Apc5N, predicted to form two α-helices, are disorderedX-ray X.l. Apc4X-ray X.l. Apc5X-ray
2.5 Å —
2.1 Å —
— 2.0 Å
a 
b 
Fig. 3. Comparison of EM density maps of APC/CCdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4.
(a) Stereoview of the EM density map and Apc4 coordinates. Main chain is shown as a cartoon. (b) Stereoview of the
2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is shown as a cartoon.
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No EM density is visible for the loop (residues 170–
205) connecting Apc5N with Apc5TPR, and thus, as
predicted, this loop is disordered. In the crystal
structure, residues 164–168 from the TEV cleavage
site continue the α7 helix, similar in structure to α7 of
human Apc5N defined in the EM density map. DALI
searches [47] revealed weak structural similarity to the
RNPassembly factor (Table 1), although the biological
significance of this similarity is unclear.
Supplementary Figure 4 shows a comparison of
the EM density and X-ray (2Fo − Fc) maps of human
Apc5 and Xenopus Apc5N. The maps determined to
resolutions of 3.6 Å and 2.2 Å, respectively, show
clear differences in structural detail, although side
chains are well resolved in both maps. Trp29 of
Apc5N adopts different rotamer conformations in the
two structures. The “outward”-facing conformer
observed in the crystal structure is hindered in the
context of the APC/C due to the close proximity of
Apc5TPR.
A model for Apc5TPR was derived using the TPR
superhelix of Schizosaccharomyces pombe Apc6
comprising 14 contiguous TPR motifs [35] as a
template using Phyre2 [53]. The 3.6-Å-resolution EM
density map of human APC/CCdh1.Emi1 was of
sufficient quality to fit extended TPR α-helices and
model residue side-chain conformations (Supple-
mentary Fig. 2a), resulting in a refined atomic model
[44] (Fig. 6a). Except for some instances of longer
TPR α-helices, Apc5TPR conforms well to a canon-
ical TPR superhelix, adopting a similar pitch of sevenTPR motifs per TPR superhelical turn [49]. Apc5TPR
matches most closely with the MALT regulatory
protein (DALI Z score of 23) (Table 1 and Supple-
mentary Fig. 5a). The TPR superhelices of Apc5 and
Apc6 are also similar (DALI score of 16) (Table 1 and
Supplementary Fig. 5b). The N-terminus of the TPR
superhelix is stabilized by the extended N-terminus
of the TPR-accessory subunit Apc15 that lines the
internal groove of the TPR superhelix (Fig. 6a),
reminiscent of Apc12 interactions with the C-terminal
superhelical turn of Apc6 [33,35]. The C-terminal 13
residues of Apc5 fold back into the TPR superhelix,
and this segment of Apc5, togetherwith theN-terminus
of Apc15, encloses a cavity within the C-terminus of
Apc5TPR. A 24-residue segment of Apc1 caps
the C-terminus of Apc5TPR (Fig. 6a). Apc5N and
Apc5TPR domains do not interact directly, and the
overall structure of Apc5 is dependent on its extensive
interface with Apc4 (Figs. 2a and 7a and b). The
absence of direct interactions between Apc5N and
Apc5TPR likely accommodates the conformational
change within the APC/C platform that is associated
with Cdh1 binding and the stimulation of APC/C
activity [13].
Apc4 and Apc5 interact through Apc4HBD and
Apc5TPR
Apc4 and Apc5 form extensive and stable inter-
actions, burying 6226 Å2 (Figs. 2a and 7a and b and
Table 3). A heterodimer of Apc4 and Apc5 is isolated
as a bi-product of the reconstitution of the apo-APC/
a 
b 
Fig. 4. Comparison of EM density maps of APC/CCdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4HBD.
(a) Stereoview of the EM density map and Apc4 coordinates. Main chain is shown as a cartoon, and amino acid side chains
are shown as sticks. (b) Stereoview of the 2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is
shown as a cartoon, and amino acid side chains are shown as sticks.
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can be stably coexpressed (this work and Ref. [40]).
The isolation of an Apc4–Apc5N complex indicates
that Apc5N itself interacts with Apc4, consistent with
the APC/C structure [44]. However, the tendency
of this complex to dissociate during purification
indicates that Apc5TPR is required to maintain stable
Apc4–Apc5 interactions. At the Apc4–Apc5 inter-
face, the Apc5TPR superhelix packs colinear with
Apc4HBD, with Apc5N packing against the tip of
Apc4HBD (Figs. 2a and 7a and b). The similar size of
Apc4HBD and Apc5TPR results in a complementary
interface between the two proteins. Conserved
surfaces of both subunits comprise the Apc4–Apc5
intersubunit interface (Fig. 7a and b). A stable Apc4
and Apc5 heterodimer suggests the possibility that it
exists as an intermediate subcomplex on the APC/C
assembly pathway.
Apc4 and Apc5 interactions with other APC/C
subunits
Apc4WD40 contacts the N-terminal cullin repeat
domain of Apc2. The interaction involves a conservededge of the β-toroid of Apc4WD40 (Fig. 7a and
Supplementary Fig. 2b and Table 3). Common
interacting surfaces of WD40 domains are
entry mouths to the central tunnel. In Apc4WD40 of
APC/CCdh1.Emi1, these areexposed [44] (Fig. 7a–c and
Supplementary Fig. 2b) and that on the lower surface
of the domain is 45 Å in diameter, typical of seven-
bladed β-propeller proteins. However, in Apc4WD40, a
tunnel through theβ-toroid is blocked by the interstrand
loop that connects βD4 and βA5 (Fig. 1b).
Complexes of APC/CCdh1 withUbcH10 (the initiating
E2 for human APC/C) showed that contacts to the
backside of UbcH10 rigidify the WHB domain of Apc2
(Apc2WHB) [30]. This interaction enhances both APC/
C–UbcH10 affinity and UbcH10 catalytic activity [30].
Examination of the APC/CCdh1.Hsl1–UbcH10 cryo-EM
map [44] revealed EM density linking Apc2WHB with
Apc4WD40, specifically the small insertion associated
with blade 3 (Fig. 7d). This interaction may reinforce
the position of Apc2WHB, facilitating contacts to
UbcH10, thereby contributing to the substantially
increased affinity of UbcH10 for the APC/C relative to
an isolated Apc2–Apc11 heterodimer, even though
UbcH10 only contacts Apc2 and Apc11 [30,44].
a 
b 
Fig. 5. Comparison of EM density maps of APC/CCdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4WD40.
(a) Stereoview of the 2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is shown as a cartoon, and
amino acid side chains are shown as sticks. (b) Stereoview of the EM density map and Apc4 coordinates. Main chain is
shown as a cartoon, and amino acid side chains are shown as sticks.
3307Atomic-Resolution Structures of Apc4 and Apc5In addition to its interface with Apc4, Apc5 forms
further extensive interfaces with Apc1, Apc8 and
Apc15 (Fig. 7 and Supplementary Fig. 2b and
Table 3). All three domains of Apc1 (Apc1WD40,
Apc1Mid and Apc1PC) interact with Apc5TPR. The
most substantial contacts are contributed by
Apc1WD40 and Apc1Mid, with the edge of Apc1WD40
inserting into the groove of the Apc5 TPR superhelix
(Fig. 7b). The Apc8 homodimer bridges Apc5N and
Apc5TPR (Fig. 7b and c). As described above, the
N-terminal segment of Apc15 (residues 1–25) inserts
into the superhelix of Apc5TPR, whereas residues 26–
46 of Apc15 form an α-helix that bridges Apc5N with
Apc8A (Fig. 7c).
Cryo-EM and X-ray crystallography provide
complementary information on multiprotein
complex structures
A comparison of crystal structures of individual
subunits with their conformations in the context of
multimeric complexes allows an analysis of the extent
of conformational changes resulting from multiple
intersubunit interactions. For the APC/C, regions of
Apc4 that are disordered in isolation become ordered
and stabilized as a result of intersubunit contacts withApc5 (Figs. 2a and 3). However, the side chains of
Apc4WD40, which are well defined in the crystal
structure, are less well defined in the cryo-EM map
(Fig. 5).
To obtain insights into how the other APC/C
subunits become ordered through interactions with
neighboring subunits in the context of the APC/C, we
tabulated regions of disorder of APC/C subunits as
observed in crystal structures for comparison with
disordered regions of the APC/C (Table 4). This
analysis is complicated by the fact that crystallizable
proteins often have disordered regions, either
defined as being proteolytically sensitive or predict-
ed to be disordered, removed prior to crystallization.
However, where data are available, with the excep-
tions of the C-terminal segments of Apc10 and Cdh1
(discussed below) and Apc4 noted above, there is a
good correlation between disordered regions of
APC/C subunits observed in crystal structures and in
the APC/C, for example, the C-terminal 50–60
residues of Apc3, Apc4 and Apc12, and the N-terminal
26 residues of Apc5. In contrast to their crystal
structures, the C-terminal ~20 residues of Apc10 and
Cdh1 are ordered in the APC/C due to the interaction
of their C-terminal IR (Ile-Arg) motifs with the IR
tail-binding sites of Apc3 [44]. This suggests that, for
Apc4 Apc4 
Apc5N(EM) Apc5N(EM) 
Apc5N(Xray) Apc5N(Xray) 
b 
Apc15
Apc5N 
Apc5TPR 
N C
1
2
34
5
6
7
N
Apc5N-Apc5TPR linker 
Apc1
a 
5 5 
7 7 
3 3 
4 4 8 8 
Fig. 6. Apc5 has an N-terminal helical domain (Apc5N) connected by a disordered linker to a TPR superhelix of 13 TPR
motifs (Apc5TPR). (a) Cartoon of EM structure of human Apc5 color-ramped from blue to red from N- to C-termini. The small
subunit Apc15 that contacts Apc5 is also shown. (b) Stereoview of a superimposition of Apc5N based on human Apc5N EM
coordinates (blue) and Xenopus Apc5N X-ray (yellow) coordinates. Major structural differences involve the α1/α2 and α5/
α6 loops that contact Apc4.
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mediated primarily through globular domains. Howev-
er, we note that the small intrinsically disordered
proteins Apc13 and Apc16 (for which there are no or
little crystallographic or NMR data) adopt nonglobular
structures and mediate numerous intersubunit inter-
actions in the context of the APC/C. Similarly, specific
insertions predicted as disordered within the large
globular subunits Apc1 and Apc2, for which no crystal
structures exist, alsomediate intersubunit interactions.
We have noted that, due to its position at the
periphery of the complex, the EM density of Apc4WD40
is less well defined than that for more ordered centrally
located subunits (Supplementary Figs. 2b and 6) [44].
Thus, interpretation of the Apc4WD40 cryo-EM density
of APC/CCdh1.Emi1 was guided by the Apc4 crystal
structure. Some other peripherally located domains
and subunits of the APC/C are also defined at
resolutions sufficient for definition of secondary struc-
tures (e.g., at 5–7 Å) but lower than that required for
unambiguous side-chain definition [44] (Supplemen-
tary Fig. 6). Interpretation of the EM densities
corresponding to these regions of the APC/C reliedon existing atomic models from crystal structures and
homology modeling. These include the WD40 domain
of Cdh1 (Cdh1WD40) [18], the catalytic module of
Apc2CTD [55] and Apc11 [31] and Apc7 [56]. The
catalytic module and Cdh1WD40 participate in few
contacts to neighboring subunits, and thus, their
intrinsic flexibility results in structural variability with
concomitant lower resolution in EM density maps.
This study illustrates the complementarity of X-ray
crystallography and EM approaches to the structure
determination of multimeric complexes.
Materials and Methods
Apc4 and Apc5N cloning, expression, purification and
crystallization
Overview of methods
Expression and purification of the human APC/C
complex (tagged on Apc4) [54] yielded together with
APC/C free Apc4 as identified by mass spectrometry.
Initial crystals of Apc4 were obtained using the PACT
Apc2 
Apc5TPR 
Apc11 
Apc15 
Apc4 
Apc8A 
Apc8B 
Apc1 
Apc5TPR 
Apc2 
Apc5N 
Apc11 
Apc4 
Apc8A 
Apc8B 
Apc1 
Apc5N 
Apc5TPR 
Apc5N 
Apc5TPR 
Apc4HBD 
a 
b 
Apc15 
d 
Apc4WD40 
Apc5
Apc2 
UbcH10 
Cdh1 
Apc11 
Apc15 
Apc2WHB-Apc4WD40 insert 
interface
Apc4WD40 
Apc4WD40 
Apc4HBD 
Apc2WHB 
Apc15 
Apc1WD40 Apc1PC 
Apc1Mid 
Apc4WD40 
Apc5N 
c 
Fig. 7. Apc4 and Apc5 interact with neighboring subunits through evolutionarily conserved protein–protein interfaces.
(a) Surface of Apc4 color-coded according to conservation (purple, conserved; cyan, unconserved). Contacting subunits
Apc2, Apc5 and Apc15 are shown as cartoons. (b and c) Surface of Apc5 color-coded according to conservation (purple,
conserved; cyan, unconserved). Contacting subunits Apc1, Apc4, Apc8 and Apc15 are shown as cartoons. (d) Cryo-EM
density map of the APC/CCdh1.Hsl1–UbcH10 complex, color-coded according to subunit assignments [44]. Density
connects Apc2WHB with the blade 3 insert of Apc4WD40, suggesting a direct interaction between these domains. EM
coordinates are shown.
Table 3. Intersubunit solvent-accessible surface area (Å2)
Subunit Apc4 Apc5 Apc1 Apc2 Apc8 Apc15
Apc4 — 6226 0 714 0 0
Apc5 — — 8744 0 3772 3446
Data taken from Ref. [44].
3309Atomic-Resolution Structures of Apc4 and Apc5crystallization screen, which were then optimized. Expres-
sion of Apc4 together with Apc5 and Apc15 from human, X.
laevis, Saccharomyces cerevisiae and S. pombe was
performed. An Apc4–Apc5 complex was expressed and
purified from all four species. However, attempts to
crystallize human and S. cerevisiae Apc4–Apc5 were
unsuccessful. We also determined that the N-terminus of
Table 4. Table comparing regions of disordering in APC/C subunits as observed from X-ray structures and the cryo-EM structure of APC/CCdh1.Emi1
Subunit X-ray structure EM structure. PDB code
4UI9. H.s. APC/C. Ref. [44]
Disorder prediction H.s. amino
acids (N)
— PDB code Ref. Construct Disordered regions within crystal Disordered regions — —
H.s. Apc3 4RG6 [37] 1–181, 454–830 (830) 1–4, 172–181,
768–830
171–450, 767–830 (A)b
171–450, 782–830 (B)
1–7, 94–109,
172–453, 770–830
830
H.s. Apc4 5BPW This study 1–808 (808)a 1–5, 304–317, 431–444,
458–472, 479–521, 758–808
429–438, 458–469, 758–808 1–9, 125–164,
557–570, 753–808
808
X.l. Apc5 5BPZ This study 1–163 (759) 1–26 1–26, 170–205 1–8, 166–212,
284–298, 741–755
755
H.s. Apc6 3YUM [33] 212–539 (620) 212–228, 530–539 96–126, 528–620 (A)
96–123, 534–620 (B)
1–12, 110–130,
546–620
620
S.p. Apc6 2XPI [35] 1–597 (671) 1–44, 61–80, 596–597 As above As above As above
H.s. Apc7 3FFL [56] 1–147 (599) 1–20, 77–96, 147 1–35, 111–131, 553–599 (A)
1–35, 111–131, 541–599 (B)
1–8, 60–71,
98–140, 534–599
599
S.p. Apc8 3ZN3 [34] 19–302 (565) 57–77, 136–151, 285–292 1–25, 501–508, 558–597 (A)
1–25, 501–508, 558–597 (B)
1–10, 125–167,
571–597
597
H.s. Apc10 1JHJ [70] 1–185 (185) 163–185 None 1–28, 180–185 185
H.s. Apc11 4R2Y [31] 17–84 (84) 17–20 None None 84
H.s. Apc12 3YUM [33] 1–85 (85) 27–85 26–85 1–9, 25–85 85
S.p. Apc12 2XPI [35] 1–80 (80) 25–80 As above As above As above
H.s. Apc16 4RG6 [37] 74–110 (110) 108–110 1–51 1–53, 94–110 110
S.c. Cdh1 4BH6 [39] 241–550
(566)
1–4, 549–550 1–41, 68–87, 109–124,
133–145, 164–168, 471–482
1–93, 131–146, 152–172,
490–496
496
a Numbers in parentheses indicate protein residue number.
b Letters in parentheses indicate subunit label.
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3311Atomic-Resolution Structures of Apc4 and Apc5Apc5 (residues 1–163) (Apc5N) interacts with Apc4 by
coexpressing Apc4 and Apc5N. This coexpression yielded
a huge increase of protein amounts for human, X. laevis,
S. cerevisiae and S. pombe. X. laevis Apc4–Apc5N was
crystallized, but diffraction was limited to 8 Å resolution.
After deleting the predicted unstructured C-terminal
residues 742–789 of Apc4, we purified the X. laevis
Apc4–Apc5N complex and we isolated Apc4 and Apc5N
proteins from a single purification. All of these crystallized.
Apc4 and Apc5N crystals were finally optimized for
structure determination (see below). The X. laevis Apc4
crystal structure was used as a search object to determine
the full-length human Apc4 crystal structure by molecular
replacement.
Cloning, expression, purification and crystallization
To clone X. laevis Apc4 and the Apc5 N-terminal domain,
we amplified and modified Apc41-741 and Apc51-163,E163D
(Apc5N) gene fragments by PCR from X. laevis Apc4 and
Apc5 cDNA clones and cloned them into pU1 plasmid as
previously described [54]. A double StrepII tag together with
a TEV cleavage site was attached to the C-terminus of
Apc5N. The proteins were expressed in the insect cell
baculovirus system. Protein expression with selenomethio-
nine labeling was performed in High 5 cells by a protocol
modified from Ref. [57]. In brief, 16 h post-infection, cells
from a 3.5-L culture were spun at 300g for 15 min at 22 °C,
the supernatant was discarded and the cells was resus-
pended in 2.5 L of cysteine- and methionine-free Sf900II
SFM media with 150 mg/L of L-cysteine. After starving the
cells for 6 h, the media was replaced with 3.5 L of cysteine-
and methionine-free Sf900II SFM media with 150 mg/L of
L-cysteine and 250 mg/L of L-selenomethionine (Molecular
DimensionsMD12-503). The cells were incubated under the
same conditions and were harvested for protein purification
18 h post-selenomethionine addition.
X. laevis Apc41-741 (now referred to as X. laevis Apc4)
was purified by collecting the late fractions of the Strep-
Tactin (Qiagen) wash step and was further purified by
anion-exchange chromatography Mono Q (GE Health-
care) and Superdex 200 size-exclusion chromatography
(GE Healthcare). Selenomethionine-labeled Apc4
was purified as for the native protein except for the
addition of 10 mM DTT and 5 mM ethylenediaminetet-
raacetic acid (EDTA) in the buffer. The selenomethio-
nine labeling was confirmed by mass spectrometry.
Xenopus Apc5N was purified using a combination of
Strep-Tactin, TEV cleavage, Mono Q anion-exchange
chromatography, a Ni-NTA column to trap TEV and
Superdex 75 size-exclusion chromatography.
To crystallize X. laevis Apc4, we concentrated the
protein to 3.5 mg/mL in a buffer of 20 mM Hepes (pH 8.0),
200 mM NaCl and 2 mM DTT. Initial crystals were
obtained by vapor diffusion in sitting drop in a buffer
containing 0.1 M sodium citrate 5.0, 8% (w/v) polyethylene
glycol (PEG) 8000. By seeding with the initial crystals, we
grew large crystals in a buffer containing 0.1 M sodium
citrate 5.0, 3% (w/v) PEG 8000, 250 mM magnesium
acetate, 10 mM Tris–HCl (pH 8.5), 200 mM NDSB 211,
4% (v/v) ethylene glycol and 2 mM DTT. Crystals were
cryoprotected in the same buffer with addition of 30% (v/v)
glycerol prior to freezing in liquid nitrogen.
To crystallize X. laevis Apc5N, we concentrated the
protein to 3.4 mg/mL. Plate-like crystals were grown in abuffer containing 40 mM sodium propionate, 20 mM
sodium cacodylate, 40 mM 2-[bis(2-hydroxyethyl)amino]-2-
(hydroxymethyl)propane-1,3-diol (Bistris) propane (pH 7.0)
and 25% (v/v) PEG 1500. Larger crystals were obtained by
seeding. For heavy metal labeling, we soaked crystals with
10 mM KAu(CN)2 or 1 mM ethylmercury p-toluene sulfon-
amide in a buffer containing 20 mM Hepes, 200 mM NaCl,
40 mM sodium propionate, 20 mM sodium cacodylate,
40 mM Bistris propane (pH 7.0) and 25% (v/v) PEG 1500
for 1 h before being harvested in the samebuffer with addition
of 15% (v/v) glycerol.
Human Apc4 was purified as a bi-product from the APC/
C expression system [54]. The protein was purified using a
combination of Strep-Tactin, Mono Q anion-exchange
chromatography and Superdex 200 size-exclusion chro-
matography. The protein was concentrated to 4 mg/mL in
a buffer containing 20 mM Hepes (pH 8.0), 150 mM NaCl
and 1 mM DTT. Initial crystals were obtained by vapor
diffusion in a buffer containing 20 mM sodium propionate,
10 mM sodium cacodylate, 20 mM Bistris propane
(pH 9.0) and 25% (v/v) PEG 1500. Seeding with the initial
crystals, we grew human Apc4 crystals by vapor diffusion
in a buffer containing 10 mM malic acid, 20 mM Mes,
20 mM Tris–HCl (pH 8.0), 160 mM NDSB 196, 10 mM
EDTA and 19% (v/v) PEG 1500. Crystals were incubated
in a cryoprotection buffer comprising 10 mM malic acid,
20 mM Mes, 20 mM Tris–HCl (pH 8.0), 160 mM NDSB
196, 10 mM EDTA, 22% (v/v) PEG 1500 and 20% (v/v)
ethylene glycol prior to freezing in liquid nitrogen.Data collection and processing
X. laevis Apc5N
The diffraction data for the native crystal were collected
to a resolution of 2.2 Å on I04 beamline at Diamond Light
Source. Derivative data were collected on beamline I24 for a
crystal soaked in 10 mM KAu(CN)2 for 30 min at the gold
L-III edge energy of 12.031 keV and a crystal soaked in
1 mM ethylmercury p-toluene sulfonamide for 30 min at the
mercury L-III edge energy of 12.299 keV to a resolution of
2.4 Å. Data were processed and scaled using Xds [58] and
the CCP4 program Aimless/TRUNCATE [59], respectively.
The derivatives were scaled to the native and the mean
empirical ratios between the anomalous and isomorphous
differences, andKemp [(F
+
PH − F−PH)/FPH − FP] was 5.65 for
the gold and was 5.56 for the mercury data.
X. laevis Apc4
Several native and heavy-atom derivative datasets were
collected and phasing attempts yielded reasonable
phases. However, selenomethionine derivative data gave
optimum phases with interpretable maps and were finally
used to determine the structure. Data were collected on
the Diamond Light Source I24 beamline using the
defocused beamsize of 20 μm × 20 μm. The crystal
morphology of long needles facilitated a line-scan data
collection strategy. Data were collected on the Se-edge
peak energy of 12,663 eV and three datasets from two
crystals were combined generating a 3.8-Å-resolution
peak dataset. On a later visit to I24, a high-energy remote
dataset was collected on a selenomethionine derivative
crystal to 3.2 Å resolution. These two datasets were
3312 Atomic-Resolution Structures of Apc4 and Apc5scaled using SCALEIT [59] and the mean empirical ratio
between the anomalous and dispersive differences, Kemp
[(F+PH − F−PH)/FPH − FP] was 4.0 for the peak and high
remote datasets.Human Apc4
Needle-like tiny crystals were found to be extremely
radiation sensitive. Hence, diffraction data were collected
from a large number of crystals on the microfocus
beamline I24 of Diamond Light Source. With the inspection
of Rmerge and I/σ(I) of all the collected data, datasets from
four crystals were indexed, merged and scaled with Xds
[58] and SCALEIT [59].Structure determination and refinement
Apc5N
Heavy-atom detection, refinement and phasing were
carried out using MIRAS with two derivatives in auto-
SHARP [60]. The positions and identities of three sites for
each derivative along with the observed anomalous
differences, isomorphous differences and structure factors
were input for heavy-atom parameter refinement and
phasing to autoSHARP. The data were subjected to
28 cycles of solvent flipping with the program SOLOMON.
Automatic building was carried out using ARP/wARP
giving an initial model with Rwork of 0.27 (Rfree = 0.34)
after a cycle of REFMAC [61]. TLS refinement and
rebuilding were carried out using REFMAC [61] and Coot
[62] and to yield a model with Rwork/Rfree of 0.20/0.24.X. laevis Apc4
Heavy-atom detection, refinement and phasing were
carried out using a two-wavelength anomalous diffraction
strategy in autoSHARP [60]. The positions of 14 seleno-
methionine sites were determined, and together with the
anomalous differences, the dispersive differences and
structure factors were input to SHARP for heavy-atom site
refinement and phasing. The data were subjected to
28 cycles of solvent flipping with the program SOLOMON.
Several cycles of PARROT density modification that uses
an MLHL-type likelihood target function and BUCCANEER
that is optimized for tracing protein chains at low resolution
with good phases gave an initial model with an Rwork of
0.46 (Rfree = 0.44). Extensive cycles of manual model
building and refinement with PHENIX [63] and REFMAC
[61] were performed.Human Apc4
Phases were obtained from molecular replacement
using X. laevis Apc4 as a search model, employing
PHASER [64]. Electron density maps obtained from
solvent flattening, using DM [59], were used for initial
model building. Iterative cycles of manual model building
and refinements were performed using Coot [62] and
PHENIX [63], respectively. To check for model bias, we
systematically calculated simulated annealing composite
omit maps at various stages of model building andrefinement. The refined structure was validated with
MolProbity [65].
Structure analysis
Evolutionary-conserved surfaces were determined
using ConSurf [66]. Figures were generated using
PyMOL‡. Regions of disorder in Apc4 and Apc5 were
predicted using OnD-CRF§ [45]. TPR predictions were
performed using TPRpred|| and HHrep¶ [51,52]. Protein
structure predictions were performed using Phyre2 protein
recognition servera [53].
SAXS data collection and data analysis
Apc4 was concentrated to approximately 20 mg/mL.
SAXS data were collected at the SWING beamline
(Synchrotron Soleil, Paris, France). The beamsize was
400 μm × 100 μm, the beam energy was 12.4 keV and
the flux was approximately 1012 photons per second. The
images were collected using the AVIEV170170 CCD
detector and the SAXS cell-to-detector distance was
1892 cm. The samples were loaded in gel-filtration buffer
using an online HPLC device and a Shodex_KW402.5-4F
size-exclusion column. The column and flow cell were
maintained at 10 °C and the sample holder prior to
injection was at 4 °C. Data were processed using the
beamline software FOXTROT and Guinier analysis was
performed using PRIMUS [48]. Theoretical SAXS profiles
for Apc4 were calculated and fitted to the SAXS
experimental profiles with the FoXS Web server [67].
Radius of gyration (Rg) were determined from the
experimental SAXS profile using GNOM [50] and calcu-
lated Rg using FoXS.
X-ray crystallographic maps and EM density maps were
displayed and analyzed using Coot [62] and PyMOL.
Atomic models were docked into the APC/CCdh1.Emi1
cryo-EM map [44] using Chimera [46]. Local-resolution
EM maps were calculated using ResMap [68].
Accession numbers
Coordinates and structure factors have been deposited
in the Protein Data Bank with accession numbers 5BPW,
5BPT and 5BPZ for human and Xenopus Apc4 and
Xenopus Apc5N, respectively.Acknowledgements
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